{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:31:18Z","timestamp":1794846678914,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19ek0109311h0001"],"award-info":[{"award-number":["19ek0109311h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We examined the clinical manifestations of acute encephalopathy (AE) and identify risk factors for AE in children with tuberous sclerosis complex (TSC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The clinical data of 11 children with clinically diagnosed TSC associated with AE and 109 children with clinically diagnosed TSC alone aged 4\u00a0years or older were collected from 13 hospitals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 11 children with AE, 5 had histories of febrile seizures (FS), and all had histories of febrile status epilepticus (FSE). AE developed within 24\u00a0h after fever onset in all children with seizures lasting 30\u00a0min or longer. All children developed coma after seizure cessation. Head magnetic resonance imaging (MRI) revealed widespread abnormalities in the cerebral cortex, subcortical white matter, corpus callosum, basal ganglia, and thalamus. One child died; seven had severe neurological sequelae; and the other three, mild sequelae. Logistic regression analysis revealed that a history of FSE was correlated with the development of AE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance<\/jats:title>\n                    <jats:p>AE in children with TSC was characterized by sudden onset after fever, followed by coma, widespread brain edema evident on MRI, and poor outcomes. A history of FSE was a risk factor for the development of AE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-020-01646-8","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T14:04:06Z","timestamp":1609941846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acute encephalopathy in children with tuberous sclerosis complex"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8135-772X","authenticated-orcid":false,"given":"Shingo","family":"Numoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kurahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shiihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Okanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiro","family":"Fukuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ikeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Mimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2447-2857","authenticated-orcid":false,"given":"Akihisa","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"1646_CR1","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis Consortium Group","year":"1993","unstructured":"European Chromosome 16 Tuberous Sclerosis Consortium Group. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75:1305\u201315.","journal-title":"Cell"},{"issue":"372","key":"1646_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","volume":"23","author":"P Curatolo","year":"2008","unstructured":"Curatolo P, Bombardieri R, J\u00f3\u017awiak S. Tuberous sclerosis. Lancet. 2008;23(372):657\u201368.","journal-title":"Lancet"},{"key":"1646_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaad.2007.05.004","volume":"57","author":"RA Schwartz","year":"2007","unstructured":"Schwartz RA, Fern\u00e1ndez G, Kotulska K, J\u00f3\u017awiak S. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dematol. 2007;57:189\u2013202.","journal-title":"J Am Acad Dematol"},{"key":"1646_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/2319-4170.110365","volume":"36","author":"M Wong","year":"2013","unstructured":"Wong M. Mammalian target of rapamycin(mTOR) pathways in neurological diseases. Biomed J. 2013;36:40\u201350.","journal-title":"Biomed J"},{"key":"1646_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fnmol.2014.00018","volume":"7","author":"CL Lasarge","year":"2014","unstructured":"Lasarge CL, Danzer SC. Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation. Front Mol Neurosci. 2014;7:18.","journal-title":"Front Mol Neurosci"},{"key":"1646_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","volume":"12","author":"JC Kingswood","year":"2017","unstructured":"Kingswood JC, d\u2019Aug\u00e8res GB, Belousova E, Ferreira JC, Carter T, Castellana R, et al. TuberOus SClerosis registry to increase disease Awareness (TOSCA)\u2014baseline data on 2093 patients. Orphanet J Rare Dis. 2017;12:2.","journal-title":"Orphanet J Rare Dis"},{"key":"1646_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345\u201356.","journal-title":"N Engl J Med"},{"key":"1646_CR8","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","volume":"51","author":"CJ Chu-Shore","year":"2010","unstructured":"Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia. 2010;51:1236\u201341.","journal-title":"Epilepsia"},{"key":"1646_CR9","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/j.1528-1167.2005.00266.x","volume":"46","author":"EH Kossoff","year":"2005","unstructured":"Kossoff EH, Thiele EA, Pfeifer HH, Muzykewicz D, Thiele EA. Tuberous sclerosis complex and ketogenic diet. Epilepsia. 2005;46:1684\u20136.","journal-title":"Epilepsia"},{"key":"1646_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ejpn.2012.05.004","volume":"16","author":"P Curatolo","year":"2012","unstructured":"Curatolo P, J\u00f3\u017awiak S, Nabbout R. Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol. 2012;16:582\u20136.","journal-title":"Eur J Paediatr Neurol"},{"key":"1646_CR11","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","volume":"66","author":"CW Shepherd","year":"1991","unstructured":"Shepherd CW, Gomez MR, Lie JT, Crowson CS. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc. 1991;66:792\u20136.","journal-title":"Mayo Clin Proc"},{"key":"1646_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2147\/TCRM.S138576","volume":"13","author":"HS Shehata","year":"2017","unstructured":"Shehata HS, AbdelGhaffar HM, Nasreldin M, Elmazny A, Abdelalim A, Sabbah A, et al. Clinical patterns and outcomes of status epilepticus in patients with tuberous sclerosis complex. Ther Clin Risk Manag. 2017;13:779\u201385.","journal-title":"Ther Clin Risk Manag"},{"key":"1646_CR13","doi-asserted-by":"publisher","first-page":"e15545","DOI":"10.1097\/MD.0000000000015545","volume":"98","author":"X Liu","year":"2019","unstructured":"Liu X, Zhang Y, Hao Y, Chen Y, Chen C. Tuberous sclerosis complex presenting as convulsive status epilepticus followed by hypoxic cerebropathy: a case report. Medicine (Baltimore). 2019;98:e15545.","journal-title":"Medicine (Baltimore)"},{"issue":"49","key":"1646_CR14","first-page":"243","volume":"2013","author":"Northrup H, Krueger DA. International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the","year":"2012","unstructured":"Northrup H, Krueger DA. International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the. Iinternational tuberous sclerosis complex consensus conference. Pediatr Neurol. 2012;2013(49):243\u201354.","journal-title":"Pediatr Neurol"},{"key":"1646_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1528-1167.2011.03311.x","volume":"53","author":"A Okumura","year":"2012","unstructured":"Okumura A, Uematsu M, Imataka G, Tanaka M, Okanishi T, Kubota T, et al. Acute encephalopathy in children with Dravet syndrome. Epilepsia. 2012;53:79\u201386.","journal-title":"Epilepsia"},{"key":"1646_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.braindev.2016.11.010","volume":"39","author":"T Okanishi","year":"2017","unstructured":"Okanishi T, Fujimoto A, Motoi H, Kanai S, Nishimura M, Yamazoe T, et al. Total corpus callosotomy for epileptic spasms after acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) in a case with tuberous sclerosis complex. Brain Dev. 2017;39:431\u20134.","journal-title":"Brain Dev"},{"key":"1646_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"R Kanda","year":"2013","unstructured":"Kanda R. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"1646_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/0036554021000026986","volume":"35","author":"T Ichiyama","year":"2003","unstructured":"Ichiyama T, Isumi H, Ozawa H, Matsubara T, Morishima T, Furukawa S. Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy. Scand J Infect Dis. 2003;35:59\u201361.","journal-title":"Scand J Infect Dis"},{"key":"1646_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.pediatrneurol.2011.09.007","volume":"45","author":"SM Kansagra","year":"2011","unstructured":"Kansagra SM, Gallentine WB. Cytokine storm of acute necrotizing encephalopathy. Pediatr Neurol. 2011;45:400\u20132.","journal-title":"Pediatr Neurol"},{"key":"1646_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-0404.2007.00809.x","volume":"186","author":"M Mizuguchi","year":"2007","unstructured":"Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand Suppl. 2007;186:45\u201356.","journal-title":"Acta Neurol Scand Suppl"},{"key":"1646_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/dmcn.13727","volume":"60","author":"X Tian","year":"2018","unstructured":"Tian X, Ye J, Zeng Q, Zhang J, Yang X, Liu A, et al. The clinical outcome and neuroimaging of acute encephalopathy after status epilepticus in Dravet syndrome. Dev Med Child Neurol. 2018;60:566\u201373.","journal-title":"Dev Med Child Neurol"},{"key":"1646_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.yebeh.2015.04.061","volume":"49","author":"P Chiewthanakul","year":"2015","unstructured":"Chiewthanakul P, Noppaklao P, Sawanyawisuth K, Tiamkao S. Hyperglycemia associated with seizure control in status epilepticus. Epilepsy Behav. 2015;49:155\u20137.","journal-title":"Epilepsy Behav"},{"key":"1646_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.seizure.2008.09.005","volume":"18","author":"R Rathakrishnan","year":"2009","unstructured":"Rathakrishnan R, Sidik NP, Huak CY, Wilder-Smith EP. Generalised convulsive status epilepticus in Singapore: clinical outcomes and potential prognostic markers. Seizure. 2009;18:202\u20135.","journal-title":"Seizure"},{"key":"1646_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.braindev.2018.11.001","volume":"41","author":"T Shima","year":"2019","unstructured":"Shima T, Okumura A, Kurahashi H, Numoto S, Abe S, Ikeno M, et al. A nationwide survey of norovirus-associated encephalitis\/encephalopathy in Japan. Brain Dev. 2019;41:263\u201370.","journal-title":"Brain Dev"},{"key":"1646_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","volume":"366","author":"R Silbergleit","year":"2012","unstructured":"Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366:591\u2013600.","journal-title":"N Engl J Med"},{"key":"1646_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","volume":"14","author":"JP Betjemann","year":"2015","unstructured":"Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol. 2015;14:615\u201324.","journal-title":"Lancet Neurol"},{"key":"1646_CR27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s40263-015-0271-x","volume":"29","author":"F Brigo","year":"2015","unstructured":"Brigo F, Nardone R, Tezzon F, Trinka E. A common reference-based indirect comparison meta-analysis of buccal versus intranasal midazolam for early status epilepticus. CNS Drugs. 2015;29:741\u201357.","journal-title":"CNS Drugs"},{"key":"1646_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.yebeh.2015.02.030","volume":"49","author":"F Brigo","year":"2015","unstructured":"Brigo F, Nardone R, Tezzon F, Trinka E. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: a systematic review with meta-analysis. Epilepsy Behav. 2015;49:325\u201336.","journal-title":"Epilepsy Behav"},{"key":"1646_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.eplepsyres.2018.03.017","volume":"142","author":"JJ Lin","year":"2018","unstructured":"Lin JJ, Wang Y, Lan SY, Chan OW, Hsia SH, Chou ML, et al. Combination of intravenous immunoglobulin and steroid pulse therapy improves outcomes of febrile refractory status epilepticus. Epilepsy Res. 2018;142:100\u20135.","journal-title":"Epilepsy Res"},{"key":"1646_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.seizure.2016.12.017","volume":"45","author":"FA Zeiler","year":"2017","unstructured":"Zeiler FA, Matuszczak M, Teitelbaum J, Kazina CJ, Gillman LM. Intravenous immunoglobulins for refractory status epilepticus, part I: a scoping systematic review of the adult literature. Seizure. 2017;45:172\u201380.","journal-title":"Seizure"},{"key":"1646_CR31","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa1608193","volume":"375","author":"S Legriel","year":"2016","unstructured":"Legriel S, Lemiale V, Schenck M, Chelly J, Laurent V, Daviaud F, et al. Hypothermia for neuroprotection in convulsive status epilepticus. N Engl J Med. 2016;375:2457\u201367.","journal-title":"N Engl J Med"},{"key":"1646_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/ana.25008","volume":"82","author":"ES Rosenthal","year":"2017","unstructured":"Rosenthal ES, Claassen J, Wainwright MS, Husain AM, Vaitkevicius H, Raines S, et al. Brexanolone as adjunctive therapy in super-refractory status epilepticus. Ann Neurol. 2017;82:342\u201352.","journal-title":"Ann Neurol"},{"key":"1646_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.seizure.2017.10.005","volume":"53","author":"KO Welin","year":"2017","unstructured":"Welin KO, Carlqvist P, Svensson A, et al. Epilepsy in tuberous sclerosis patients in Sweden\u2014healthcare utilization, treatment, morbidity, and mortality using national register data. Seizure. 2017;53:4\u20139.","journal-title":"Seizure"},{"key":"1646_CR34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/dmcn.13352","volume":"59","author":"S Amin","year":"2017","unstructured":"Amin S, Lux A, Calder N, Althin R, Eklund E, Rask O. Causes of mortality in individuals with tuberous sclerosis complex. Dev Med Child Neurol. 2017;59:612\u20137.","journal-title":"Dev Med Child Neurol"},{"key":"1646_CR35","doi-asserted-by":"publisher","first-page":"106550","DOI":"10.1016\/j.yebeh.2019.106550","volume":"101","author":"BC Peter","year":"2019","unstructured":"Peter BC. Mechanistic target of rapamycin (mTOR) signaling in status epilepticus. Epilepsy Behav. 2019;101:106550.","journal-title":"Epilepsy Behav"},{"key":"1646_CR36","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/j.1528-1167.2010.02640.x","volume":"51","author":"A Escayg","year":"2010","unstructured":"Escayg A, Goldin AL. Sodium channel SCN1A and epilepsy: mutations and mechanisms. Epilepsia. 2010;51:1650\u20138.","journal-title":"Epilepsia"},{"key":"1646_CR37","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/j.1528-1167.2012.03649.x","volume":"53","author":"C Marini","year":"2012","unstructured":"Marini C, Darra F, Specchio N, Mei D, Terracciano A, Parmeggiani L, et al. Focal seizures with affective symptoms are a major feature of PCDH19 gene-related epilepsy. Epilepsia. 2012;53:2111\u20139.","journal-title":"Epilepsia"},{"key":"1646_CR38","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1212\/WNL.0000000000004384","volume":"89","author":"YH Zhang","year":"2017","unstructured":"Zhang YH, Burgess R, Malone JP, Glubb GC, Helbig KL, Vadlamudi L, et al. Genetic epilepsy with febrile seizures plus: refining the spectrum. Neurology. 2017;89:1210\u20139.","journal-title":"Neurology"},{"key":"1646_CR39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1542\/peds.86.4.611","volume":"86","author":"J Maytal","year":"1990","unstructured":"Maytal J, Shinnar S. Febrile status epilepticus. Pediatrics. 1990;86:611\u20136.","journal-title":"Pediatrics"},{"key":"1646_CR40","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/epi.13418","volume":"57","author":"DC Hesdorffer","year":"2016","unstructured":"Hesdorffer DC, Shinnar S, Lax DN, Wood R. Risk factors for subsequent febrile seizures in the FEBSTAT study. Epilepsia. 2016;57:1042\u20137.","journal-title":"Epilepsia"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01646-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-01646-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01646-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T15:24:01Z","timestamp":1670685841000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01646-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1646"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01646-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-36304\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-36304\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"16 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is approved by the Ethics Committee of Aichi Medical University Hospital. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this manuscript is consistent with those guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Anonymized data and materials can be made available upon reasonable request to the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}